West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95,600 | 127,100 | 112,300 | 80,700 | 75,500 |
| Depreciation Amortization | 89,900 | 90,000 | 85,200 | 76,900 | 75,700 |
| Income taxes - deferred | -8,900 | 7,000 | 1,700 | 5,300 | 2,900 |
| Accounts receivable | -14,100 | -6,300 | -9,100 | -25,700 | -25,500 |
| Accounts payable and accrued liabilities | 17,200 | -3,500 | 4,600 | 5,800 | 24,600 |
| Other Working Capital | -10,800 | -30,600 | -3,700 | -3,300 | -21,100 |
| Other Operating Activity | 43,500 | -800 | 29,500 | 47,700 | -1,400 |
| Operating Cash Flow | $212,400 | $182,900 | $220,500 | $187,400 | $130,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,500 | 4,900 | 14,400 | -25,600 |
| PPE Investments | -131,600 | -111,900 | -151,900 | -131,300 | -95,400 |
| Net Acquisitions | N/A | N/A | -3,900 | N/A | N/A |
| Purchase Of Investment | -1,500 | -500 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -200 | N/A | -700 | -1,400 |
| Other Investing Activity | 3,600 | 900 | 1,000 | 900 | 500 |
| Investing Cash Flow | $-129,500 | $-104,000 | $-149,900 | $-116,000 | $-120,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 263,400 | 43,200 | 168,100 | 200 |
| Debt Repayment | 44,000 | -285,700 | 262,200 | 352,400 | 192,700 |
| Common Stock Issued | 15,900 | 17,100 | 24,200 | 10,900 | 5,800 |
| Common Stock Repurchased | -5,600 | -4,100 | -5,200 | -4,700 | -3,500 |
| Dividend Paid | -32,400 | -29,100 | -26,700 | -24,900 | -23,200 |
| Other Financing Activity | -63,400 | 7,600 | -302,800 | -505,200 | -196,700 |
| Financing Cash Flow | $-41,500 | $-30,800 | $-5,100 | $-3,400 | $-24,700 |
| Exchange Rate Effect | -22,100 | -22,800 | 2,600 | 2,100 | -3,900 |
| Beginning Cash Position | 255,300 | 230,000 | 161,900 | 91,800 | 110,200 |
| End Cash Position | 274,600 | 255,300 | 230,000 | 161,900 | 91,800 |
| Net Cash Flow | $19,300 | $25,300 | $68,100 | $70,100 | $-18,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 212,400 | 182,900 | 220,500 | 187,400 | 130,700 |
| Capital Expenditure | -131,600 | -111,900 | -151,900 | -131,300 | -95,400 |
| Free Cash Flow | 80,800 | 71,000 | 68,600 | 56,100 | 35,300 |